Nanoterra

Category·JANUARY 22, 2026

A perfectly normal title for a corporate blog article

by Joaquim Araujo

Nanoterra has been investing in nanobiotechnology for years and bringing its benefits to people, businesses and communities. Whether publishing state-of-the-art research, building useful products or creating tools that enable others, we are committed to making science accessible.

We are at a pivotal moment in that journey. Breakthroughs in plant-derived nanoactives are fundamentally changing how the industry formulates its products — and we keep developing these technologies responsibly so we can safely bring them to market.

More than three billion people already benefit from cosmetics made with naturally derived ingredients. Now we are taking the next step and opening up to a limited group of partners a new set of actives that makes developing sustainable formulations even simpler.

In practice, you start from the effect you want on the skin and arrive at a viable formulation route. So an R&D team starting a new project saves the time and effort involved in the first rounds of bench work.

People worry that computers will get too smart and take over the world, but the real problem is that they're too stupid and they've already taken over the world.

Pedro Domingos

Latest articles

Category·March 13, 2026

A perfectly normal title for a corporate blog article

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse dapibus congue condimentum. In sed gravida turpis. Aliquam erat volutpat.

Read more

Category·March 13, 2026

A perfectly normal title for a corporate blog article

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse dapibus congue condimentum. In sed gravida turpis. Aliquam erat volutpat.

Read more

Category·February 27, 2026

A perfectly normal title for a corporate blog article

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse dapibus congue condimentum. In sed gravida turpis. Aliquam erat volutpat.

Read more

Receive new articles in your inbox

Sign up to be the first to receive our blog's latest news.